Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-05

Clinical Trial Update: The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether vitamin D and calcium supplementation modulates parathyroid hormone in patients with chronic hepatitis B on tenofovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium carbonate (Calcium carbonate)
  • Parathyroid hormone (Parathyroid hormone)
  • Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)
  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Mahidol University | Conditions: Parathyroid Hormone, Tenofovir Disoproxil Fumarate | Phase 4 | Status: COMPLETED